相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Identification of a unique endoplasmic retention motif in the Xenopus GIRK5 channel and its contribution to oocyte maturation
Claudia I. Rangel-Garcia et al.
FEBS OPEN BIO (2021)
HER2-targeted therapies - a role beyond breast cancer
Do-Youn Oh et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Tumour-agnostic therapies
Ann-Marie Looney et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Aspartate β-hydroxylase as a target for cancer therapy
Madiha Kanwal et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
Diverse molecular functions of aspartate β-hydroxylase in cancer
Wenqian Zheng et al.
ONCOLOGY REPORTS (2020)
Pan-cancer analysis of somatic mutations in miRNA genes
Martyna O. Urbanek-Trzeciak et al.
EBIOMEDICINE (2020)
Labyrinthin, The Tumor Marker Recognized By MCA 44-3A6: A Case For Pan-Tumor Markers As Targets To Treat Cancer
James A. Radosevich et al.
ONCOTARGETS AND THERAPY (2019)
Therapeutic Cancer Vaccine and Combinations With Antiangiogenic Therapies and Immune Checkpoint Blockade
Alice Mougel et al.
FRONTIERS IN IMMUNOLOGY (2019)
Alternative tumour-specific antigens
Christof C. Smith et al.
NATURE REVIEWS CANCER (2019)
Microsatellite Instability: A Predictive Biomarker for Cancer Immunotherapy
Liisa Chang et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2018)
Hydroxylase Activity of ASPH Promotes Hepatocellular Carcinoma Metastasis Through Epithelial-to-Mesenchymal Transition Pathway
Qifei Zou et al.
EBIOMEDICINE (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Development of a novel anti-human aspartyl-(asparaginyl) β-hydroxylase monoclonal antibody with diagnostic and therapeutic potential
Ting Huyan et al.
ONCOLOGY LETTERS (2017)
Aspartate β-hydroxylase disrupts mitochondrial DNA stability and function in hepatocellular carcinoma
C. Tang et al.
ONCOGENESIS (2017)
Preclinical and clinical development of neoantigen vaccines
L. Li et al.
ANNALS OF ONCOLOGY (2017)
Altered calcium signaling in cancer cells
Teneale A. Stewart et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2015)
The aspartyl (asparaginyl) beta-hydroxylase in carcinomas
Hui Yang et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2015)
Evaluation of HAAH/humbug quantitative detection in the diagnosis of hepatocellular carcinoma
Tian Xue et al.
ONCOLOGY REPORTS (2015)
Aspartate β-hydroxylase expression promotes a malignant pancreatic cellular phenotype
Xiaoqun Dong et al.
ONCOTARGET (2015)
A Cell-Surface β-Hydroxylase Is a Biomarker and Therapeutic Target for Hepatocellular Carcinoma
Arihiro Aihara et al.
HEPATOLOGY (2014)
Inhibition of human natural killer cell functional activity by human aspartyl β-hydroxylase
Ting Huyan et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2014)
Immunization with aspartate-β-hydroxylase-loaded dendritic cells produces antitumor effects in a rat model of intrahepatic cholangiocarcinoma
Takehiro Noda et al.
HEPATOLOGY (2012)
Tumor progression-related transmembrane protein aspartate-β-hydroxylase is a target for immunotherapy of hepatocellular carcinoma
Masafumi Shimoda et al.
JOURNAL OF HEPATOLOGY (2012)
The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
Martin A. Cheever et al.
CLINICAL CANCER RESEARCH (2009)
Monoclonal Antibodies Against Human Aspartyl (Asparaginyl) beta-Hydroxylase Developed by DNA Immunization
Tao Xue et al.
HYBRIDOMA (2009)
Minor sarcoplasmic reticulum membrane components that modulate excitation-contraction coupling in striated muscles
Susan Treves et al.
JOURNAL OF PHYSIOLOGY-LONDON (2009)
Impaired placentation in fetal alcohol syndrome
F. Gundogan et al.
PLACENTA (2008)
Multiple functions of junctin and junctate, two distinct isoforms of aspartyl beta-hydroxylase
Chang-Soo Hong et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Aspartyl-asparagyl β hydroxylase over-expression in human hepatoma is linked to activation of insulin-like growth factor and notch signaling mechanisms
M. Chiara Cantarini et al.
HEPATOLOGY (2006)
Clinicopathological correlates of aspartyl(asparaginyl)beta-hydroxylase over-expression in cholangiocarcinoma
T Maeda et al.
CANCER DETECTION AND PREVENTION (2004)
Endoplasmic reticulum export of glycosyltransferases depends on interaction of a cytoplasmic dibasic motif with sar1
CG Giraudo et al.
MOLECULAR BIOLOGY OF THE CELL (2003)
Antisense oligodeoxynucleotides directed against aspartyl (asparaginyl) β-hydroxylase suppress migration of cholangiocarcinoma cells
T Maeda et al.
JOURNAL OF HEPATOLOGY (2003)
Forward transport: 14-3-3 binding overcomes retention in endoplasmic reticulum by dibasic signals
I O'Kelly et al.
CELL (2002)
Antisense oligonucleotides selectively regulate aspartyl β-hydroxylase and its truncated protein isoform in vitro but distribute poorly into A549 tumors in vivo
SP Ho et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Role of the aspartyl-asparaginyl-β-hydroxylase gene in neuroblastoma cell motility
PS Sepe et al.
LABORATORY INVESTIGATION (2002)
Human aspartyl (asparaginyl) β-hydroxylase monoclonal antibodies:: Potential biomarkers for pancreatic carcinoma
KS Palumbo et al.
PANCREAS (2002)
Absence of post-translational aspartyl β-hydroxylation of epidermal growth factor domains in mice leads to developmental defects and an increased incidence of intestinal neoplasia
JE Dinchuk et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Adjacent basic amino acid residues recognized by the COPI complex and ubiquitination govern endoplasmic reticulum to cell surface trafficking of the nicotinic acetylcholine receptor α-subunit
SH Keller et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Molecular cloning, expression, functional characterization, chromosomal localization, and gene structure of junctate, a novel integral calcium binding protein of sarco(endo)plasmic reticulum membrane
S Treves et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Aspartyl β-hydroxylase (Asph) and an evolutionarily conserved isoform of Asph missing the catalytic domain share exons with junctin
JE Dinchuk et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
